Cutting-edge breakthroughs in DNA production, from high-yield plasmid manufacturing to next-generation cell-free platforms, are transforming how biopharma develops advanced vaccines and nucleic acid-based therapeutics. Organizations across the space are accelerating investment in technologies that enhance upstream fermentation efficiency, streamline downstream purification, and strengthen CMC frameworks for rapid, compliant scale-up.

Date and Time: Tuesday, 24 March 2026 at 08:00 – Thursday, 26 March 2026 at 17:00

Venue details: Hotel Commonwealth, 500 Commonwealth Avenue, Boston, Massachusetts, 02215, United States